Cargando…
“Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
European Respiratory Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487684/ https://www.ncbi.nlm.nih.gov/pubmed/26324819 http://dx.doi.org/10.1183/09059180.50011514 |
_version_ | 1784792505414320128 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9487684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-94876842022-11-14 “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. Eur Respir Rev Author Correction European Respiratory Society 2015-09 /pmc/articles/PMC9487684/ /pubmed/26324819 http://dx.doi.org/10.1183/09059180.50011514 Text en Copyright ©ERS 2015. https://creativecommons.org/licenses/by-nc/4.0/ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Author Correction “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. |
title | “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. |
title_full | “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. |
title_fullStr | “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. |
title_full_unstemmed | “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. |
title_short | “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. |
title_sort | “long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” vincent cottin and toby maher. eur respir rev 2015; 24: 58–64. |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487684/ https://www.ncbi.nlm.nih.gov/pubmed/26324819 http://dx.doi.org/10.1183/09059180.50011514 |